GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Deferred Tax

Philogen SpA (STU:78Q) Deferred Tax : €-4.92 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Philogen SpA's change in deferred tax for the six months ended in Dec. 2024 was €-4.92 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was €-4.92 Mil.

Philogen SpA Deferred Tax Historical Data

The historical data trend for Philogen SpA's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Deferred Tax Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
0.87 0.49 1.02 -0.02 -4.92

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.44 0.59 -0.61 0.01 -4.92

Philogen SpA Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-4.92 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen SpA Deferred Tax Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Deferred Tax
Comparable Companies
MIL:UBM MIL:ARBS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN HKSE:02269 SHSE:603392
Traded in Other Exchanges
PHIL:Italy 78Q:Germany
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Website
https://www.philogen.com
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines